ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3093; 2) Community: the network communities that were significantly associated with the response to NSC 3093; 3) Molecule: the relationships between components within communities and NSC 3093; 4) MDR: the compounds that were significantly associated with the NSC 3093.

NSC Compound Enrichment Correlation
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.045446901295916 0.22523142
NSC 697886 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] 0.045446901295916 0.33852921
NSC 698408 Null 0.045446901295916 0.29159664
NSC 699680 Z-.alpha.-Chlorochalcone 0.045446901295916 0.40150369
NSC 702158 7-epi-3,4-bis-nor-dolastatin 11 0.045446901295916 0.34801539
NSC 705437 Null 0.045446901295916 0.062061644
NSC 706995 Entinostat 0.045446901295916 0.094795969
NSC 717065 Null 0.045446901295916 0.23319366
NSC 722982 Null 0.045446901295916 0.30593648
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.045446901295916 0.056145637
Total:65  Current:57    [First] [Prev] [Next] [Last]